ProCE Banner Activity

CE / CME

Influenza Vaccination: Integrating Best Practices and Optimizing Care to Reduce Disease Burden and Increase Vaccine Uptake

Multimedia

Listen to expert faculty as they discuss best practices for reducing the burden of disease and increasing vaccine uptake.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit™

Nurses: 1.00 Nursing contact hour

Released: October 21, 2022

Expiration: October 20, 2023

Begin Activity

Share

Faculty

Paul G. Auwaerter

Paul G. Auwaerter, MD, MBA

Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Rachel Macleod

Rachel Macleod, PharmD, BCIDP, AAHIVP

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
Ascension Genesys Hospital
Grand Blanc, Michigan

Provided by

Provided by Clinical Care Options, LLC, in partnership with ProCE, LLC, and in collaboration with the Society of Infectious Diseases Pharmacists

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant by Seqirus USA Inc.

Seqirus USA Inc

Partners

Society of Infectious Diseases Pharmacists (SIDP)

ProCE Banner

Target Audience

This program is intended for physicians, nurses, pharmacists, and other HCPs who treat and manage patients at risk for influenza.

Program Learning Goal

The goal of this activity is to improve and accelerate the awareness, understanding, and integration of current and emerging best practices in influenza vaccination.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the current and evolving landscape of seasonal influenza activity, particularly in relation to the impact of the COVID-19 pandemic

  • Compare available influenza vaccination formulations and identify optimization approaches based on seasonal and patient-specific factors

  • Apply effective strategies to improve influenza vaccination rates including identifying and addressing vaccine hesitancy

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Paul G. Auwaerter, MD: consultant/advisor/speaker: EMD Serono, Humanigen, Pfizer; individual publicly traded stocks and stock options: Johnson & Johnson; investor: Wellstat.

Rachel Macleod, PharmD, BCIDP, AAHIVP, has no relevant financial relationships to disclose.

Instructions for Credit

Learners wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form

The estimated time to complete this activity is 1.0 hour. Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 65%. 

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Paul G. Auwaerter, MD: consultant/advisor/speaker: EMD Serono, Humanigen, Pfizer; individual publicly traded stocks and stock options: Johnson & Johnson; investor: Wellstat.

Rachel Macleod, PharmD, BCIDP, AAHIVP, has no relevant financial relationships to disclose.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education


Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008176-0000-22-264-H01-P.
Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.